$ALT
Altimmune Inc Stock $alt

$alt Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-K Financial Statement

#000114420416087617 Filed on March 11, 2016

Income Statement

Concept	2015 Q4	2015	2014 Q4
Revenue	$1.270M	$10.64M	$1.830M
YoY Change	-30.6%	4.42%	-49.86%
Cost Of Revenue	-$50.00K	-$50.00K
YoY Change
Gross Profit	$1.320M	$10.69M
YoY Change
Gross Profit Margin	103.94%	100.47%
Selling, General & Admin	$980.0K	$6.220M	$2.620M
YoY Change	-62.6%	-42.99%	-42.79%
% of Gross Profit	74.24%	58.19%
Research & Development	$1.170M	$5.134M	$1.790M
YoY Change	-34.64%	-44.92%	-56.34%
% of Gross Profit	88.64%	48.02%
Depreciation & Amortization	$30.00K	$141.6K	$40.00K
YoY Change	-25.0%	-5.57%	0.0%
% of Gross Profit	2.27%	1.32%
Operating Expenses	$2.180M	$14.04M	$4.450M
YoY Change	-51.01%	-31.1%	-48.97%
Operating Profit	-$940.5K	-$3.403M	-$2.624M
YoY Change	-64.15%	-66.61%	-48.23%
Interest Expense	-$280.0K	$54.58K	$10.00K
YoY Change	-2900.0%	-74.06%	-98.48%
% of Operating Profit
Other Income/Expense, Net	$0.00	$23.84K	$0.00
YoY Change		-91.99%
Pretax Income	-$1.220M	-$3.379M	-$2.620M
YoY Change	-53.44%	-65.85%	-40.59%
Income Tax	$20.00K	$61.75K	$10.00K
% Of Pretax Income
Net Earnings	-$1.238M	-$3.441M	-$2.629M
YoY Change	-52.9%	-65.44%	-40.57%
Net Earnings / Revenue	-97.51%	-32.34%	-143.68%
Basic Earnings Per Share	-$0.02	-$0.05	-$0.04
Diluted Earnings Per Share	-$0.02	-$0.05	-$0.04
COMMON SHARES
Basic Shares Outstanding	64.45M shares	63.99M shares	63.37M shares
Diluted Shares Outstanding		63.99M shares

Balance Sheet

Concept	2015 Q4	2015	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.60M	$15.60M	$18.60M
YoY Change	-16.13%	-16.13%	77.14%
Cash & Equivalents	$15.57M	$9.100M	$18.64M
Short-Term Investments	$6.400M	$6.400M	$6.400M
Other Short-Term Assets	$200.0K	$200.0K	$200.0K
YoY Change	0.0%	0.0%	0.0%
Inventory
Prepaid Expenses
Receivables	$1.500M	$1.500M	$400.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$17.23M	$17.20M	$19.25M
YoY Change	-10.51%	-10.88%	34.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$233.7K	$200.0K	$325.8K
YoY Change	-28.26%	-33.33%	-15.62%
Goodwill	$22.49M		$2.348M
YoY Change	857.85%		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$53.38K	$100.0K	$53.38K
YoY Change	0.0%	0.0%	-18.7%
Total Long-Term Assets	$2.636M	$2.700M	$2.728M
YoY Change	-3.38%	0.0%	-2.59%
TOTAL ASSETS
Total Short-Term Assets	$17.23M	$17.20M	$19.25M
Total Long-Term Assets	$2.636M	$2.700M	$2.728M
Total Assets	$19.86M	$19.90M	$21.98M
YoY Change	-9.63%	-9.55%	28.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$521.1K	$500.0K	$391.4K
YoY Change	33.14%	25.0%	-65.31%
Accrued Expenses	$1.600M	$1.500M	$1.200M
YoY Change	33.33%	36.36%	-62.5%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$746.1K
YoY Change	-100.0%	-100.0%	-25.39%
Total Short-Term Liabilities	$2.179M	$2.200M	$2.582M
YoY Change	-15.58%	-15.38%	-62.01%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$433.4K	$1.000M	$493.1K
YoY Change	-12.11%	-9.09%	-16.24%
Total Long-Term Liabilities	$433.4K	$1.000M	$493.1K
YoY Change	-12.11%	-9.09%	-62.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.179M	$2.200M	$2.582M
Total Long-Term Liabilities	$433.4K	$1.000M	$493.1K
Total Liabilities	$3.213M	$3.200M	$3.704M
YoY Change	-13.25%	-13.51%	-62.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$223.7M		-$220.3M
YoY Change	1.56%		4.73%
Common Stock	$6.438K		$238.8M
YoY Change	-100.0%		9.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$43.13M	$16.60M	$18.27M
YoY Change
Total Liabilities & Shareholders Equity	$19.86M	$19.90M	$21.98M
YoY Change	-9.63%	-9.55%	28.23%

Cashflow Statement

Concept	2015 Q4	2015	2014 Q4
OPERATING ACTIVITIES
Net Income	-$1.238M	-$3.441M	-$2.629M
YoY Change	-52.9%	-65.44%	-40.57%
Depreciation, Depletion And Amortization	$30.00K	$141.6K	$40.00K
YoY Change	-25.0%	-5.57%	0.0%
Cash From Operating Activities	-$1.830M	-$3.220M	-$3.520M
YoY Change	-48.01%	-61.98%	-43.77%
INVESTING ACTIVITIES
Capital Expenditures	-$20.00K	$86.51K	$0.00
YoY Change		-6.24%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$10.00K	$0.00
YoY Change		0.0%
Cash From Investing Activities	-$20.00K	-$80.00K	$0.00
YoY Change		0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$973.1K
YoY Change		-94.64%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	30.00K	220.0K	2.550M
YoY Change	-98.82%	-98.68%	222.78%
NET CHANGE
Cash From Operating Activities	-1.830M	-3.220M	-3.520M
Cash From Investing Activities	-20.00K	-80.00K	0.000
Cash From Financing Activities	30.00K	220.0K	2.550M
Net Change In Cash	-1.820M	-3.080M	-970.0K
YoY Change	87.63%	-137.65%	-82.27%
FREE CASH FLOW
Cash From Operating Activities	-$1.830M	-$3.220M	-$3.520M
Capital Expenditures	-$20.00K	$86.51K	$0.00
Free Cash Flow	-$1.810M	-$3.307M	-$3.520M
YoY Change	-48.58%	-61.38%	-43.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	us-gaap	Goodwill Goodwill	2348453	USD
CY2014Q4	us-gaap	Goodwill Goodwill	2348453	USD
CY2015Q4	us-gaap	Assets Assets	19862397	USD
CY2014Q4	us-gaap	Assets Assets	21978241	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	521122	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	391396	USD
CY2015Q4	pip	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	1248708	USD
CY2014Q4	pip	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	1195412	USD
CY2015Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	381950	USD
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q2	dei	Entity Public Float EntityPublicFloat	81000000	USD
CY2015	dei	Trading Symbol TradingSymbol	PIP
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	65251230	shares
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15569813	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18643351	USD
CY2015Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	511994	USD
CY2014Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	110656	USD
CY2015Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	963345	USD
CY2014Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	297431	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	181714	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	199194	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	17226866	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	19250632	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	233694	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	325772	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53384	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53384	USD
CY2014Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	0	USD
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	746146	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	11250	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	70326	USD
CY2015Q4	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	16411	USD
CY2014Q4	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	178509	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2179441	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2581789	USD
CY2015Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	108641	USD
CY2014Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	0	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	433407	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	493137	USD
CY2015Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	491791	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	629170	USD
CY2015Q4	us-gaap	Liabilities Liabilities	3213280	USD
CY2014Q4	us-gaap	Liabilities Liabilities	3704096	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	6438	USD
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0001326190
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Entity Registrant Name EntityRegistrantName	PHARMATHENE, INC
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3378959	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61746	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61746	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-11718353	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1382	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	336	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	61746	USD
CY2015	us-gaap	Paid In Kind Interest PaidInKindInterest	-45358	USD
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	7600	USD
CY2013	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	2546159	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2013	us-gaap	Depreciation Depreciation	182487	USD
CY2015	us-gaap	Depreciation Depreciation	141604	USD
CY2014	us-gaap	Depreciation Depreciation	149958	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	28751815	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-9955395	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	6360	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	240366704	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	238780633	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-223724025	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-220283320	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-229528	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	16649117	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	18274145	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19862397	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21978241	USD
CY2013	us-gaap	Contracts Revenue ContractsRevenue	17912607	USD
CY2015	us-gaap	Contracts Revenue ContractsRevenue	10640660	USD
CY2014	us-gaap	Contracts Revenue ContractsRevenue	10190205	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15290142	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5133512	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9319828	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13279186	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6222185	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10911724	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	14043460	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	20381510	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-10839208	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-3402800	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-10191305	USD
CY2013	us-gaap	Interest Expense InterestExpense	366706	USD
CY2015	us-gaap	Interest Expense InterestExpense	54581	USD
CY2014	us-gaap	Interest Expense InterestExpense	210399	USD
CY2013	pip	Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation	0	USD
CY2015	pip	Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation	229192	USD
CY2014	pip	Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation	0	USD
CY2013	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-444622	USD
CY2015	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	299477	USD
CY2014	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	508817	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6071	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8137	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-762	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-817399	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	23841	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	297656	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-11656607	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9893649	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61746	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-3440705	USD
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	50659116	shares
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	63986013	shares
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57535325	shares
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-10818	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-229192	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11719735	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3211177	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9966213	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	613017	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	1655647	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	61746	USD
CY2014	us-gaap	Paid In Kind Interest PaidInKindInterest	83021	USD
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5394	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	401338	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1316457	USD
CY2015	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	665914	USD
CY2014	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-1902094	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5202	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5367	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	129726	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-736776	USD
CY2015	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	481761	USD
CY2014	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	0	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-54818	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2089493	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-341723	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3215981	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-8474042	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	86507	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	92269	USD
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7600	USD
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-78907	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-84269	USD
CY2015	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-750007	USD
CY2014	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-999996	USD
CY2015	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
CY2014	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-1091740	USD
CY2015	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2014	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	683325	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	973132	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18141935	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	223125	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	16733524	USD
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1775	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-12841	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3073538	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	8162372	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10480979	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1362716	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64382086	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63603303	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64382086	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63603303	shares
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	1362716	USD
CY2013	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-238767	USD
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6018891	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	5030127	USD
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1382	USD
CY2015	us-gaap	Interest Paid InterestPaid	108391	USD
CY2014	us-gaap	Interest Paid InterestPaid	128073	USD
CY2015Q4	pip	Billed And Unbilled Accounts Receivable Net BilledAndUnbilledAccountsReceivableNet	1500000	USD
CY2015Q4	pip	Additional Common Stock Aggregate Gross Sales AdditionalCommonStockAggregateGrossSales	3000000	USD
CY2015Q4	pip	Maximum Amount Of Reimbursement MaximumAmountOfReimbursement	210000	USD
CY2015Q4	pip	Annual License Payment AnnualLicensePayment	200000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	613017	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1655647	USD
CY2015	pip	Share Based Compensation Extension Of Exercise Period ShareBasedCompensationExtensionOfExercisePeriod	75000	USD
CY2015	pip	Share Based Compensation Reversal From Stock Option Forfeitures ShareBasedCompensationReversalFromStockOptionForfeitures	129000	USD
CY2015	pip	Share Based Compensation Reversal Net ShareBasedCompensationReversalNet	53741	USD
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6500000	shares
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11900000	shares
CY2015	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	36981	USD
CY2015Q4	us-gaap	Property Subject To Or Available For Operating Lease Net PropertySubjectToOrAvailableForOperatingLeaseNet	0	USD
CY2015Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	250128	USD
CY2015Q4	us-gaap	Accrued Rent Noncurrent AccruedRentNoncurrent	108641	USD
CY2015	pip	Warrant Expiration Date WarrantExpirationDate	2015-01-28
CY2015Q1	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	194600000	USD
CY2015Q1	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	113100000	USD
CY2015Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	81500000	USD
CY2015Q3	pip	Maximum Amount Of Reimbursement MaximumAmountOfReimbursement	210000	USD
CY2015Q3	pip	Annual License Payment AnnualLicensePayment	200000	USD
CY2015Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1422781	shares
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	61746	USD
CY2013	us-gaap	Paid In Kind Interest PaidInKindInterest	135162	USD
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	3500	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1005528	USD
CY2013	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-1914917	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-282057	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-569120	USD
CY2013	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	0	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	773566	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1040032	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7168204	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	84579	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3500	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-81079	USD
CY2013	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-749997	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2220538	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12701517	USD
CY2013	us-gaap	Interest Paid InterestPaid	234119	USD
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i>Use of Estimates</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Our consolidated financial statements include significant estimates for the expected economic life and value of our tangible assets and value of our indefinite lived intangible asset, the amount of our net operating losses, our share-based compensation, and financial instruments, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	8900	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1649994	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	455840	USD
CY2014	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	5653	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	11673840	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5944095	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1352117	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	74796	USD
CY2013	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	10599	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	7335712	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17686095	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	613017	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	973132	USD
CY2014	pip	Shares Issued Upon Exercise Of Warrants SharesIssuedUponExerciseOfWarrants	1107064	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1857256	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2188703	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2090950	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2514475	USD
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	451805	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	540722	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	600390	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	509953	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	102632	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	37313	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	93881	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	107424	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	65635003	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	64361842	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	61590084	USD
CY2015Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	139853	USD
CY2014Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	166205	USD
CY2013Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	148395	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3834	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1726	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2352660	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	6909	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-6274	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2706156	USD
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	68482	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3458334	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3368571	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	91210	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	366797	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	859358	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	68227626	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	68357012	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	65968134	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2015Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2014Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2013Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2015Q4	pip	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	68227626	USD
CY2014Q4	pip	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	68357012	USD
CY2013Q4	pip	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	65968134	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	68608401	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	68676033	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	66225409	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	380775	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	319021	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	257275	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1148846	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3363841	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3963246	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-124626	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-450656	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1179476	USD
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	7913	USD
CY2013	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-710512	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	1218	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	794807	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-369407	USD
CY2015	pip	Lobbying Costs LobbyingCosts	1047	USD
CY2014	pip	Lobbying Costs LobbyingCosts	57517	USD
CY2013	pip	Lobbying Costs LobbyingCosts	98507	USD
CY2015	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	-1049765	USD
CY2014	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	-380689	USD
CY2013	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	0	USD
CY2015	pip	Income Tax Reconciliation Limitation Deferred Write Off IncomeTaxReconciliationLimitationDeferredWriteOff	0	USD
CY2014	pip	Income Tax Reconciliation Limitation Deferred Write Off IncomeTaxReconciliationLimitationDeferredWriteOff	0	USD
CY2013	pip	Income Tax Reconciliation Limitation Deferred Write Off IncomeTaxReconciliationLimitationDeferredWriteOff	6246942	USD
CY2015	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	2949	USD
CY2014	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-308	USD
CY2013	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-1816	USD
CY2015	pip	Income Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	-143102	USD
CY2014	pip	Income Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	-2580153	USD
CY2013	pip	Income Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	-2585164	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	204848	USD
CY2013	us-gaap	Maintenance Costs MaintenanceCosts	40000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.86	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y8M12D
CY2014Q3	us-gaap	Contracts Revenue ContractsRevenue	962451	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2401866	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1169871	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3996030	USD
CY2014Q4	us-gaap	Contracts Revenue ContractsRevenue	1826296	USD
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2623538	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-2258440	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-439120	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2641899	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2646910	USD
CY2015Q1	us-gaap	Contracts Revenue ContractsRevenue	7068746	USD
CY2015Q2	us-gaap	Contracts Revenue ContractsRevenue	1149570	USD
CY2015Q3	us-gaap	Contracts Revenue ContractsRevenue	1155839	USD
CY2015Q4	us-gaap	Contracts Revenue ContractsRevenue	1266505	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1161084	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1964867	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1658548	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-940469	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	1463395	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-2340932	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-1324768	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-1238400	USD
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2014Q1	us-gaap	Contracts Revenue ContractsRevenue	3742525	USD
CY2014Q2	us-gaap	Contracts Revenue ContractsRevenue	3658933	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-4628435	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-2629400	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2015Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	508202	USD
CY2015Q3	pip	Initial Fund Value InitialFundValue	5200000	USD
CY2015Q3	pip	Additional Fund Value AdditionalFundValue	4900000	USD
CY2015Q3	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	28100000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	400000	USD
CY2015Q1	us-gaap	Restructuring And Related Cost Expected Cost1 RestructuringAndRelatedCostExpectedCost1	2000000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	848273	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	356911	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1205184	USD
CY2015	us-gaap	License Costs LicenseCosts	300000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.7	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.84	pure
CY2013	us-gaap	Fair Value Assumptions Weighted Average Volatility Rate FairValueAssumptionsWeightedAverageVolatilityRate	0.5	pure
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y1M6D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y7M6D
CY2015	us-gaap	Fair Value Assumptions Weighted Average Volatility Rate FairValueAssumptionsWeightedAverageVolatilityRate	0.5	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0150	pure
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	800000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0151	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0225	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0096	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0190	pure
CY2015	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	2546159	USD
CY2015	us-gaap	Payments For Restructuring PaymentsForRestructuring	2050830	USD
CY2015	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	4738	USD
CY2015Q4	us-gaap	Restructuring And Related Cost Expected Cost Remaining1 RestructuringAndRelatedCostExpectedCostRemaining1	490591	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11600000	shares
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	500000	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100000	USD
CY2013	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	20000	USD
CY2014	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	0	USD
CY2015	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	0	USD
CY2013Q1	pip	Common Stock Aggregate Amount Equity Offering CommonStockAggregateAmountEquityOffering	15000000	USD
CY2015	pip	Stock Sales Agent Commission Percentage StockSalesAgentCommissionPercentage	0.030	pure
CY2015Q4	pip	Equity Offering Remaining Aggregate Sales Available EquityOfferingRemainingAggregateSalesAvailable	3000000	USD
CY2014	pip	Offering Costs In Connection With Controlled Equity Offering Sales Agreement OfferingCostsInConnectionWithControlledEquityOfferingSalesAgreement	100000	USD
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i>Concentration of Credit Risk</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i> </i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Financial instruments that potentially subject us to concentrations of credit risk are primarily cash and cash equivalents, and billed and unbilled accounts receivable. We maintain our cash and cash equivalents in the form of money market accounts and overnight deposits with financial institutions that we believe are credit worthy. Because our billed and unbilled accounts receivable consist of amounts due from the U.S. Government, there is minimal credit risk.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4495556	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	700000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1300000	USD
CY2015Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	800000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2015	pip	Restructuring Expense Related To Property And Equipment RestructuringExpenseRelatedToPropertyAndEquipment	36981	USD
CY2014	pip	Restructuring Expense Related To Property And Equipment RestructuringExpenseRelatedToPropertyAndEquipment	0	USD
CY2013	pip	Restructuring Expense Related To Property And Equipment RestructuringExpenseRelatedToPropertyAndEquipment	0	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	800000	USD
CY2015	us-gaap	Maintenance Costs MaintenanceCosts	100000	USD
CY2013Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5620128	shares
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	USD
CY2014	us-gaap	Maintenance Costs MaintenanceCosts	100000	USD
CY2015	pip	Percentage Of Common Stock Delivered PercentageOfCommonStockDelivered	1	pure
CY2015Q4	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	205000000	USD
CY2015Q1	us-gaap	Government Contract Receivable Progess Payments Offset GovernmentContractReceivableProgessPaymentsOffset	5800000	USD
CY2015	pip	Operating Lease Term OperatingLeaseTerm	P10Y
CY2015	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	200000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.13
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.30
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.23
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	300000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	USD
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	800000	USD
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1400000	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1400000	USD
CY2014Q2	pip	Common Stock Aggregate Amount Equity Offering CommonStockAggregateAmountEquityOffering	15000000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0225	pure
CY2015Q4	pip	Beneficial Ownership Percentage Held By Affiliates BeneficialOwnershipPercentageHeldByAffiliates	0.0499	pure

Files In Submission

Name	View Source	Status
0001144204-16-087617-index-headers.html	Edgar Link	pending
0001144204-16-087617-index.html	Edgar Link	pending
0001144204-16-087617.txt	Edgar Link	pending
0001144204-16-087617-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pip-20151231.xml	Edgar Link	completed
pip-20151231.xsd	Edgar Link	pending
pip-20151231_cal.xml	Edgar Link	unprocessable
pip-20151231_def.xml	Edgar Link	unprocessable
pip-20151231_lab.xml	Edgar Link	unprocessable
pip-20151231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tpg28.jpg	Edgar Link	pending
v433058_10k.htm	Edgar Link	pending
v433058_ex10-3013.htm	Edgar Link	pending
v433058_ex21.htm	Edgar Link	pending
v433058_ex23.htm	Edgar Link	pending
v433058_ex31-1.htm	Edgar Link	pending
v433058_ex31-2.htm	Edgar Link	pending
v433058_ex32-1.htm	Edgar Link	pending
v433058_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALT
Altimmune Inc Stock $alt

2015 Q4 Form 10-K Financial Statement

#000114420416087617 Filed on March 11, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT Altimmune Inc Stock $alt

2015 Q4 Form 10-K Financial Statement

#000114420416087617 Filed on March 11, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT
Altimmune Inc Stock $alt